Saurabh Sinha was named Chief Financial Officer of Arteris, Inc., effective September 8, 2026. As of November 6, 2026, Arteris, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 12, 2026 to August 6, 2026, naming 1 appointment and 1 departure (Form 8-K, August 6, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Arteris, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Arteris, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-12 to 2026-08-06. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as Arteris, Inc. files it.
Also on the record for Arteris, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 27, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 6.2% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by NEEDHAM INVESTMENT MANAGEMENT L.L.C. | 7.8% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Arteris, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Arteris, Inc. and the records around it.
Arteris, Inc. elsewhere on the record
Companies that share a holder
- NEEDHAM INVESTMENT MANAGEMENT L.L.C. also filed stake reports on 13 other companies: Aspen Aerogels Inc (Aug 2026), Elmet Group Co. (Aug 2026), LANTRONIX INC (Jul 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch Arteris, Inc.
Get an email when Arteris, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Arteris, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Arteris, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Arteris, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-08-06 | In | Chief Financial Officer | 2026-09-08 | 8-K, 2026-08-06 | |
| 2026-05-12 | Out | Chief Financial Officer | 2026-08-31 | 8-K, 2026-05-12 |
Who leads Arteris, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer: Saurabh Sinha, appointed, effective 2026-09-08 (filed 2026-08-06).
New leaders reset buying decisions — get the Full Report on Arteris, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer at Arteris, Inc., with the record behind each one.
Find candidates like Chief Financial Officer at Arteris, Inc.Every change, in the filing's words
Appointed: Saurabh Sinha, Chief Financial Officer, effective 2026-09-08
Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On August 3, 2026, the Board of Directors (the "Board") of Arteris, Inc. (the "Company") appointed Saurabh Sinha as the Company's Chief Financial Officer, effective as of September 8, 2026 (the "Start Date").
- Mr. Sinha will also serve as the Company's principal financial officer and principal accounting officer.
- Prior to this appointment, Mr. Sinha had served as Aeva Technologies, Inc.'s Chief Financial Officer since September 2020.
- Prior to joining Aeva, Mr. Sinha was the Chief Accounting Officer of JUUL Labs from July 2018 to August 2020 and served as its interim Chief Financial Officer from January 2020 to May 2020.
- Prior to joining JUUL Labs, Mr. Sinha held various finance leadership roles, from March 2014 to June 2018, at InvenSense Inc., a motion sensors company.
- Mr. Sinha received his Bachelor of Commerce degree from the University of Delhi, India and his Master of Business Administration from The Wharton School of the University of Pennsylvania.
- The Company entered into an offer letter with Mr. Sinha dated July 16, 2026 (the "Offer Letter") which provides that, among other things, Mr. Sinha will receive an annual base salary of $440,000, and will be eligible to participate in the Company's Management Performance Bonus Plan with a target bonus opportunity of 60% of Mr. Sinha's annual base salary, based on the attainment of one or more pre-established performance goals.
Departing: Nick Hawkins, Chief Financial Officer, effective 2026-08-31
On May 8, 2026, Nick Hawkins, Chief Financial Officer of the Company, notified the Company he will retire effective August 31, 2026.
- Mr. Hawkins will continue to serve as an advisor to the Company after his retirement date to facilitate an orderly transition.
- Mr Hawkins' decision to retire is due to an illness in his family and is not the result of any disagreement with the Company or its independent registered public accountants on any matter relating to the Company's financial statements, operations, policies or practices.
- The Board of Directors of the Company has initiated a comprehensive search for a new Chief Financial Officer.
Tools for this story
Each opens in a new tab, filled in for Arteris, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.